PVF in Decongestion of Heart Failure

Status Recruiting

Clinical Trial Summary

Evaluate PVF alterations in patients with ADHF at arrival and after decongestive treatment

Clinical Trial Description

Hospitalizations from heart failure have been shown to be preceded by a gradual increase in cardiac filling pressures using invasive ambulatory monitoring measurements [1, 2]., this technique does not directly assess congestion. The use of point-of-care ultrasound (POCUS) to evaluate lung congestion has been shown to decrease decompensations and urgent heart failure visits [3, 4]. However, besides lung congestion, the abdominal compartment contributes significantly to deranged cardiac as well as renal function in congestive heart failure (CHF) [5].There is increasing recognition that worsening renal function in CHF is related to altered renal blood flow [6, 7]. Recently, alterations in renal venous flow (IRVF) assessed by Doppler imaging have been associated with worse outcomes in patients with CHF [8, 9]. Besides IRVF alterations, portal vein flow (PVF) alterations have been proposed as a marker of venous congestion and right ventricular dysfunction [10, 11]. PVF and IRVF alterations have been shown to correlate with each other and were independently associated with the development of subsequent acute kidney injury (AKI) in patients undergoing cardiac surgery [12, 13]. Portal vein (PV) Doppler is easily obtainable and less time consuming than intra renal venous Doppler. Given the potential usefulness of evaluating venous congestion via POCUS of PVF, we decided to study the dynamic changes that occur during decongestion in patients presenting with heart failure to the emergency department Optimal method for noninvasive assessment of venous congestion remains an unresolved issue. Portal vein (PV) and intra renal venous flow alterations are markers of abdominal venous congestion and have been associated with acute kidney injury (AKI) in cardiac surgery patients. It is currently unknown if portal vein flow (PVF) alterations in heart failure can be reversed with diuretic treatment and track decongestion ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05227872
Study type	Observational
Source	Assiut University
Contact	Mohamed S Hassanien, Res
Phone	+201156625520
Email	mhmdsh94.inv@gmail.com
Status	Recruiting
Phase
Start date	October 30, 2021
Completion date	December 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03727646` - Nicotinamide Riboside in LVAD Recipients	Early Phase 1
Withdrawn	`NCT03519477` - Comprehensive Medication Monitoring on Heart Failure Patient Outcomes	N/A
Recruiting	`NCT05596760` - Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers	N/A
Recruiting	`NCT05543720` - Evaluation of Nurse-led Integrated Care of Complex Patients Facilitated By Telemonitoring: The SMaRT Study	N/A
Completed	`NCT04572425` - Virtual Reality for Pain Management in Advanced Heart Failure	N/A
Recruiting	`NCT03202329` - Evaluation of Post-operative, Nurse-based Heart Failure Care in Non-cardiac Surgery	N/A
Recruiting	`NCT03830957` - Efficacy and Safety of Ivabradine to Reduce Heart Rate Prior to Coronary CT-angiography in Advanced Heart Failure: Comparison With β-Blocker	N/A
Recruiting	`NCT02672618` - Clinical Research to Explore Manifestations of Heart Failure Using Infrared Thermal Imaging Technology	N/A
Recruiting	`NCT04179643` - NAN-101 in Patients With Class III Heart Failure	Phase 1
Completed	`NCT04129658` - Heart Failure in Southern Sweden
Not yet recruiting	`NCT05591443` - Artificial Intelligence and Smart Wearable Technologies for Early Detection of Acute Heart Failure
Completed	`NCT03387813` - Hemodynamic-GUIDEd Management of Heart Failure	N/A
Completed	`NCT03187470` - Left Ventricular Dyssynchrony in Multipole Pacing	N/A
Completed	`NCT04628325` - Effects of Furosemide Plus Small HSS in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)	Phase 3
Completed	`NCT03385837` - Activity Level and Barriers to Participate of Cardiac Rehabilitation in Advanced Heart Failure Patients
Completed	`NCT04281849` - Balance, Aerobic Capacity, Mobility and Strength in Patients Hospitalized for Heart Failure (BAMS-HF) Program	N/A
Not yet recruiting	`NCT04403659` - Telemonitoring of Patients Admitted in Hospital at Home With Acute Decompensated Heart Failure - Pilot Study	N/A
Terminated	`NCT04142788` - RELieving Increasing oEdema Due to Heart Failure	Phase 4
Active, not recruiting	`NCT04283994` - Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2)	N/A
Completed	`NCT03722069` - Dietary Sodium Intake in Acute Heart Failure	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.